Previous Close | 39.4 |
1-Year Change | 118.04% |
6-Months Change | -33.63% |
3-Months Change | 17.82% |
Moving Avg (50d) | 38.194 |
Moving Avg (200d) | 41.887 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 2.69B |
Beta (3-Years) | 1.76 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -121.37% |
EPS (ttm) | -7.22 |
PE Ratio (ttm) | -5.46 |
Dividend Yield | % |
Asset Description: | Biohaven Ltd. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-16 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
38.612 | 37.43 | 36.642 | 35.46 | 33.49 | 31.52 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |